SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.7600
-0.0099 (-1.29%)
At close: May 23, 2025, 4:00 PM
0.7760
+0.0160 (2.11%)
After-hours: May 23, 2025, 4:04 PM EDT
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $30.25 million as of May 23, 2025. Its market cap has decreased by -56.48% in one year.
Market Cap
30.25M
Enterprise Value
-7.87M
1-Year Change
-56.48%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $30.25M, a decrease of -60.25%. That is a compound annual growth rate of -8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 30.30M | -33.99% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |